Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
She is an active researcher and an experienced science writer
When considering current recommendations from the ADA for add-on therapy to metformin in patients not achieving individualized glycemic goals, PIONEER 2 provides valuable data comparing the addition of either an oral GLP-1 receptor agonist or an SGLT-2 inhibitor
Bonner C, Kerr-Conte J, Gmyr V, et al
There was a stagnant interest in PCT drugs, as recently demonstrated by other researchers ( Of the 63 samples, SERMs were declared in 21 (33.3%), AIs in 16 (25.4%), and other PCT substances in 26 (41.3%)
US$ 22.22
US$ 28.48
US$ 22.76
US$ 29.65
